Serena Williams showed off her slim figure in a bold swimsuit after revealing she’s been using a weight-loss medication. The ...

Fox News senior medical analyst Dr. Marc Siegel joins 'Fox News Live' to discuss how tennis icon Serena Williams was able to ...

“Most users tolerate GLP-1 medications like Ozempic without serious oral health issues, but a subset experience notable side ...

The weight-loss drug Wegovy just got FDA approval to treat a common and serious liver condition known as MASH (Metabolic ...

Anecdotal reports describe an unusual GLP-1 side effect some are calling "Ozempic vulva," which involves sagging skin, ...

New research reveals that GLP-1 receptor agonists significantly lower mortality risk in older cancer patients with type 2 ...

Dr. Sterling Elliott, Clinical pharmacist at Northwestern Medicine and assistant professor of orthopaedics at Feinberg School ...

A study has found that adults with obesity taking GLP-1 receptor agonists may face significantly lower risk of developing certain cancers. The cohort study was led by researchers from the Indiana ...

Mounjaro and other GLP-1 drugs may lower cancer risk in obese patients, according to a new study. Read more here.

People with type 2 diabetes treated with GLP-1 receptor agonists may face a slightly higher risk for eye complications ...

As cancer progression has been linked with high glucose, adiposity, insulin resistance, and systemic inflammation, investigators studied several glucose-lowering drugs in relationship to cancer ...

GLP-1 drugs were also associated with a slight increase in risk for kidney cancer. The increase was not statistically ...